beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8) , 1313-1317
- https://doi.org/10.1128/aac.33.8.1313
Abstract
The in vitro activity of four oral cephalosporins was assessed in dilution tests with 50 isolates of the family Enterobacteriaceae possessing well-characterized mechanisms of resistance to beta-lactam antibiotics. The interaction of the drugs with a broad array of beta-lactamases was also determined in spectrophotometric assays and tests for enzyme induction. Overall, the percentages of strains susceptible to each of the study drugs were 82% for cefixime, 62% for cefuroxime, 58% for cephalexin, and 44% for cefaclor. The poor activity of the older cephalosporins was due to a high degree of susceptibility to hydrolysis by both plasmid-mediated and chromosomally mediated beta-lactamases. For cefaclor, higher MICs were associated with higher levels of plasmid-mediated beta-lactamases in the strains. Resistance to cefuroxime was seen primarily among strains expressing high levels of class I or IV beta-lactamase. Resistance to cefixime was seen only among strains expressing high levels of class I enzymes. Neither cefixime nor cefuroxime was a strong inducer of class I beta-lactamases, although enzyme induction did appear to play a role in cefuroxime resistance in a strain of Serratia marcescens. The consistently greater activity of cefixime over cefuroxime was found not to be due to greater drug permeation into the cell. Rather, it appeared to result from the high affinity of the drug for target enzymes.This publication has 30 references indexed in Scilit:
- Comparative in-vitro activity of a new oral carbacephem, LV163892Journal of Antimicrobial Chemotherapy, 1988
- In vitro activity and beta-lactamase stability of LY163892European Journal of Clinical Microbiology & Infectious Diseases, 1988
- In-vitro activity and β-lactamase stability of LY163892Journal of Antimicrobial Chemotherapy, 1988
- Cefuroxime axetilJournal of Antimicrobial Chemotherapy, 1988
- BMY-28100, a new oral cephalosporin: Antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolatesDiagnostic Microbiology and Infectious Disease, 1988
- Comparable Evaluation of Orally Active Beta-Lactam Compounds in Ampicillin-Resistant Gram-Positive and Gram-Negative Rods: Role of Beta-Lactamases on ResistanceChemotherapy, 1988
- In vitro evaluations of U-76,252 (CS-807): Antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionDiagnostic Microbiology and Infectious Disease, 1987
- Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892European Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefiximeThe Pediatric Infectious Disease Journal, 1987
- In vitro evaluation of cefixime (FK027, FR17027, CL284635): Spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteriaDiagnostic Microbiology and Infectious Disease, 1986